ES2139247T3 - Derivados de 6-polifluoralcoxi y de 6-polifluoralquilo-2-aminobenzotiazoles. - Google Patents

Derivados de 6-polifluoralcoxi y de 6-polifluoralquilo-2-aminobenzotiazoles.

Info

Publication number
ES2139247T3
ES2139247T3 ES95935997T ES95935997T ES2139247T3 ES 2139247 T3 ES2139247 T3 ES 2139247T3 ES 95935997 T ES95935997 T ES 95935997T ES 95935997 T ES95935997 T ES 95935997T ES 2139247 T3 ES2139247 T3 ES 2139247T3
Authority
ES
Spain
Prior art keywords
pct
polifluoralquilo
polifluoralcoxi
aminobenzotiazoles
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95935997T
Other languages
English (en)
Inventor
Philip Chapelle
Claude Gaillard
Patrick Jimonet
Erik Louvel
Michel Martinet
Serge Mignani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Application granted granted Critical
Publication of ES2139247T3 publication Critical patent/ES2139247T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

COMPUESTOS DE FORMULA (I), EN LA QUE R REPRESENTA UN RADICAL POLIFLUOROALCOXI O POLIFLUOROALQUILO Y BIEN R{SUB,1 REPRESENTA UN ATOMO DE HIDROGENO O BIEN R{SUB,2} REPRESENTA UN RADICAL HIDROXI, O BIEN R{SUB,1} REPRESENTA UN RADICAL HIDROXI Y R{SUB,2} REPRESENTA UN ATOMO DE HIDROGENO, SUS SALES, SU PREPARACION Y LOS MEDICAMENTOS QUE LOS CONTIENEN.
ES95935997T 1994-10-26 1995-10-23 Derivados de 6-polifluoralcoxi y de 6-polifluoralquilo-2-aminobenzotiazoles. Expired - Lifetime ES2139247T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9412796A FR2726271B1 (fr) 1994-10-26 1994-10-26 Derives de 6-polyfluoroalcoxy-2-aminobenzothiazole

Publications (1)

Publication Number Publication Date
ES2139247T3 true ES2139247T3 (es) 2000-02-01

Family

ID=9468224

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95935997T Expired - Lifetime ES2139247T3 (es) 1994-10-26 1995-10-23 Derivados de 6-polifluoralcoxi y de 6-polifluoralquilo-2-aminobenzotiazoles.

Country Status (12)

Country Link
US (1) US5795903A (es)
EP (1) EP0788491B1 (es)
JP (1) JP3882198B2 (es)
AT (1) ATE187169T1 (es)
AU (1) AU3809095A (es)
DE (1) DE69513679T2 (es)
DK (1) DK0788491T3 (es)
ES (1) ES2139247T3 (es)
FR (1) FR2726271B1 (es)
GR (1) GR3032022T3 (es)
WO (1) WO1996013492A1 (es)
ZA (1) ZA958861B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
US5824662A (en) 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
HUP0001062A3 (en) 1996-09-27 2001-09-28 Guilford Pharmaceuticals Inc B Pharmaceutical compositions of phosphinic acid derivatives having naaladase inhibitor acivity
FR2774592B1 (fr) * 1998-02-06 2000-03-17 Rhone Poulenc Rorer Sa Application du 2-amino-6-trifluoromethoxybenzothiazole pour la prevention ou le traitement des dysfonctionnements du cervelet
EP1416931B1 (en) * 2001-08-13 2007-06-13 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Inhibitors of polyq-aggregation
EP1620413A2 (en) * 2003-04-30 2006-02-01 Cytokinetics, Inc. Compounds, compositions, and methods
WO2005077343A2 (de) * 2004-02-11 2005-08-25 Max-Delbrück-Centrum für Molekulare Medizin Neue arzneimittel und diagnostische zusammensetzungen für behandlung und diagnose von neurodegenerativen erkrankungen und amyloid-krankheiten
KR102378845B1 (ko) 2017-03-30 2022-03-24 엑스더블유파마 리미티드 이환형 헤테로아릴 유도체 및 이의 제조 및 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492258A1 (fr) * 1980-10-17 1982-04-23 Pharmindustrie Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole
US5236940A (en) * 1988-12-15 1993-08-17 Rhone-Poulenc Sante Pharmaceutical compositions, 2-benzothiazolamine derivatives, and their preparation
EP0374041B1 (fr) * 1988-12-15 1992-06-17 Rhone-Poulenc Sante Médicaments à base de dérivés de la benzothiazolamine-2, dérivés et leur préparation
FR2649701B2 (fr) * 1988-12-15 1991-11-22 Rhone Poulenc Sante Derives d'imino-2 benzothiazoline, leurs procedes de preparation et les medicaments les contenant

Also Published As

Publication number Publication date
EP0788491A1 (fr) 1997-08-13
JP3882198B2 (ja) 2007-02-14
ATE187169T1 (de) 1999-12-15
DK0788491T3 (da) 2000-05-08
EP0788491B1 (fr) 1999-12-01
JPH10508014A (ja) 1998-08-04
GR3032022T3 (en) 2000-03-31
US5795903A (en) 1998-08-18
ZA958861B (en) 1996-05-09
DE69513679D1 (de) 2000-01-05
FR2726271A1 (fr) 1996-05-03
WO1996013492A1 (fr) 1996-05-09
FR2726271B1 (fr) 1996-12-06
DE69513679T2 (de) 2000-06-21
AU3809095A (en) 1996-05-23

Similar Documents

Publication Publication Date Title
DE69529143T2 (de) Distamycin a analoga als antitumor- oder antivirale wirkstoffe
DK0588869T3 (da) Røntgenkontrastmiddel
AU2936195A (en) Cyclic amide derivatives for protecting against ultraviolet rays
PT91574A (pt) Procede de preparation de n-cycloalkyle benzyamines utiles comme medicaments
ES2139247T3 (es) Derivados de 6-polifluoralcoxi y de 6-polifluoralquilo-2-aminobenzotiazoles.
ES2108595A1 (es) Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion.
IT1196423B (it) Benzotiazolin-composti
FI923679A (fi) Ny b-fenylisoserinderivat, dess framstaellning och anvaendning
ES2156212T3 (es) Derivados de azabicicloheptano n-substituidos como neurolepticos, etc.
AU7899891A (en) Compounds for the treatment of age-related memory impairment and other cognitive disorders
NZ236186A (en) Pyrrolidine and piperidine derivatives and pharmaceutical compositions
MX9101948A (es) Composicion farmaceutica que contiene derivados de tiazoloisoindolinona
ATE155791T1 (de) Etoposid-derivate, ihre herstellung, ihre verwendung als medikament und ihre verwendung zur herstellung eines antikrebsmittels
ES2087567T3 (es) Derivados antibioticos de 7'-amino-naftazarina.
DE69131353T2 (de) Indolderivate
ATE205853T1 (de) Streptograminderivate, ihre herstellung und sie enthaltende pharmazeutische zubereitungen
DE69919191D1 (de) Heilmittel für die stenose des rückenmarkkanals
AU4544096A (en) New derivatives of glycylanilides, preparation and therapeutical application
BR1100189A (pt) Derivados de carboestirila

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 788491

Country of ref document: ES